Poster Presentations Session III
Poster Presentations Session III Tuesday, 7 November 2017
POSTERS SET-UP: 8:30 - 8:45
POSTERS DISPLAY HOURS: 8:45 - 13:30
POSTER AUTHOR DISCUSSION: 12:30 - 13:30
POSTERS DISMANTLE: 13:30


Poster display locations are shown below the poster codes
MEDICAL DEVICES/DIAGNOSTICS - Clinical Outcomes Studies
PMD1
A1
ISO-OSMOLAR CONTRAST MEDIA AND ADVERSE RENAL AND CARDIAC EVENTS AFTER PERCUTANEOUS CARDIOVASCULAR INTERVENTION
McCullough PA1, David G2, Todoran TM3, Brilakis ES4, Ryan MP5, Gunnarsson C5
1Baylor Heart and Vascular Institute, Dallas, TX, USA, 2The Wharton School, University of Pennsylvania, Philadelphia, PA, USA, 3Medical University of South Carolina, Charleston, SC, USA, 4Minneapolis Heart Institute, Minneapolis, MN, USA, 5CTI Clinical Trial and Consulting Services, Covington, KY, USA

PMD2
A2
ECONOMIC EVALUATION OF NT-PROBNP GUIDED THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE
Lu X, Mao Y
Roche Diagnostics Limited, Shanghai, China

PMD3
A3
THE CLINICAL AND COST-EFFECTIVENESS OF DIFFERENT MATERNAL SYPHILIS SCREENING STRATEGIES IN BRAZIL
Romero CP1, Stevenson MD2, Dixon S2
1Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil, 2University of Sheffield, Sheffield, UK

PMD4
A4
ECONOMIC ANALYSIS OF ALK RELATED COMPANION DIAGNOSIS METHODS BEFORE THE TARGETED THERAPY FOR NON-SMALL CELL LUNG CANCER
He J1, Lu X2, Mao Y2, Hu S3
1Shanghai Medical Information Center (Shanghai Health Development Research Center), Shanghai, China, 2Roche Diagnostics Limited, Shanghai, China, 3Shanghai Health Development Research Center, Shanghai, China

PMD5
A5
WHAT IS THE ECONOMIC IMPACT OF CCP TEST MISCLASSIFICATION IN RHEUMATOID ARTHRITIS DIAGNOSIS? A BENCHMARKING SIMULATION STUDY IN SPAIN.
Andalucia C, Gallo G, Mascialino B
Thermo Fisher Scientific, Uppsala, Sweden

PMD6
A6
ECONOMIC EVALUATION OF STRATEGIES FOR OPPORTUNISTIC CERVICAL CANCER SCREENING
Mao Y1, Lu X1, Chen W2
1Roche Diagnostics Limited, Shanghai, China, 2Fudan University, Shanghai, China

PMD7
A7
QUICK AND COMPREHENSIVE ASSESSMENT OF NARROW BAND IMAGING (NBI) USING IN DIGESTIVE TRACT EXAMINATION
Dou G
Fudan University, Shanghai, China

PMD8
A8
ECONOMIC EVALUATION OF STRATEGIES FOR PUBLIC CERVICAL CANCER SCREENING
Lu X1, Mao Y1, Chen W2
1Roche Diagnostics Limited, Shanghai, China, 2Fudan University, Shanghai, China

PMD9
A9
SPIROMETRY COMPARISON BETWEEN SMOKERS AND NON-SMOKERS STUDENTS IN UNIVERSITY OF BALOCHISTAN,QUETTA, PAKISTAN
Ahmed T, Iqbal Q, Minhas M
University of Balochistan, Quetta, Pakistan

PMD10
A10
INTEGRATED 2 SCREW CEPAHLO-MEDULARY DEVICE REDUCES DEVICE RELATED POST-OPERATIVE COMPLICATIONS AND PAIN AFTER INTERTROCHANTERIC FRACTURES, EVIDENCE FROM A SYSTEMATIC REVIEW AND META-ANALYSIS
Nherera L1, Trueman P1, Horner A1, Watson J2
1Smith & Nephew, Hull, UK, 2Saint Louis University, St. Louis, MO, USA

PMD11
A11
COMPARING COST-EFFECTIVENESS OF STRATEGIES FOR ANTENATAL HIV TESTING: VCT AND ROUTINE TESTING IN URBAN NIGERIA.
Ibekwe E1, Haigh C1, Prof Francis Fatoye F2
1Manchester Metropolitan University, UK, Manchester, UK, 2Manchester Metropolitan University, Manchester, UK

PMD12
A12
WITHDRAWN

PMD13
A13
TORIC INTRAOCULAR LENSES FOR THE CORRECTION OF PRE-EXISTING CORNEAL ASTIGMATISM DURING CATARACT SURGERY: A SYSTEMATIC REVIEW OF THE LITERATURE
Zignani M1, Caridad PV1, Ender F1, Breitkopf S2, Shaikh J3, O’Boyle D4
1Alcon Management SA, Geneva, Switzerland, 2Alcon Pharma GmbH, Frieburg, Germany, 3Novartis Healthcare Pvt Ltd, Hyderabad, India, 4Novartis Ireland Ltd., Dublin, Ireland

PMD14
A14
SINGLE VERSUS MULTIPLE INHALERS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): A SYSTEMATIC LITERATURE REVIEW
King D1, Zhang S2, Rosen V3, Ismaila A4
1Forest Systematic Reviews Limited, Twickenham, UK, 2GSK, Collegeville, PA, USA, 3OPTUM Life Sciences, Eden Prairie, MN, USA, 4GSK, Research Triangle Park, NC, USA

PMD15
A15
ESTIMATING THE COMPARATIVE ACCURACY OF DIAGNOSTIC TESTS: AN EXAMPLE USING TYPHOID FEVER
Arora P1, Thorlund K2, Brenner DR1, Andrews JR3
1Lighthouse Outcomes, Toronto, ON, Canada, 2McMaster University, Hamilton, ON, Canada, 3Stanford University, Palo Alto, CA, USA

PMD16
A16
INTEGRATED 2 SCREW DE-ROTATION/COMPRESSION, CEPAHLO-MEDULARY DEVICE REDUCES IMPLANT RELATED COMPLICATIONS AND IMPROVES HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH INTERTROCHANTERIC FRACTURES, A SYSTEMATIC REVIEW AND META-ANALYSIS
Nherera L1, Trueman P1, Horner A1, Watson J2
1Smith & Nephew, Hull, UK, 2Saint Louis University, St. Louis, MO, USA

PMD17
A17
HEALTH AND ECONOMIC BENEFITS OF USING SINGLE VERSUS MULTIPLE INHALERS IN PATIENTS WITH ASTHMA: A SYSTEMATIC LITERATURE REVIEW
Zhang S1, King D2, Rosen V3, Ismaila A4
1GSK, Collegeville, PA, USA, 2Forest Systematic Reviews Limited, Twickenham, UK, 3OPTUM Life Sciences, Eden Prairie, MN, USA, 4GSK, Research Triangle Park, NC, USA

PMD18
A18
EFFECT OF ACRYLIC MONOFOCAL INTRAOCULAR LENSES (IOLS) ON ND:YAG LASER CAPSULOTOMY RATES: A META-ANALYSIS
Perez Vives C1, Ender F1, deHaan J2, Breitkopf S3, Danyliv A4, Gupta S5, Samavedam S5, O'Boyle D4
1Alcon Management SA, Geneva, Switzerland, 2Alcon Nederland B.V., Vilvoorde, Belgium, 3Alcon Pharma GmbH, Frieburg, Germany, 4Novartis Ireland Limited, Dublin, Ireland, 5Novartis Healthcare Pvt Ltd, Hyderabad, India

MEDICAL DEVICES/DIAGNOSTICS - Cost Studies
PMD19
A19
IMPACT OF COMPREHENSIVE GENOMIC PROFILING OF PATIENTS WITH FIRST LINE NON-SMALL CELL LUNG CANCER IN THE UK
Anhorn R1, Roberts G2, Skovhus M2, Khorshid M3
1Foundation Medicine, Inc., Cambridge, MA, USA, 2F. Hoffmann-La Roche Ltd, Basel, Switzerland, 3F. Hoffmann-La Roche AG, Basel, Switzerland

PMD20
A20
STRUCTURED EDUCATION PROGRAM FOR INJECTION TECHNIQUE - BUDGET IMPACT MODEL
Laroche S1, Hopley C2, Bourguignon S3, Strauss K4
1Becton Dickinson, Le Pont de Claix, France, 2Becton Dickinson, Oxford, UK, 3STRATEGIQUE SANTE, Evry, France, 4Becton Dickinson, Erembodegem, Belgium

PMD21
A21
BUDGET IMPACT ANALYSIS OF DEEP BRAIN STIMULATION FOR THE TREATMENT OF PARKINSON’S DISEASE PATIENTS IN THE ITALIAN SETTING
Straziota V
Medtronic Italy, Milano, Italy

PMD22
A22
THE BUDGET IMPACT OF INTRODUCING A PD-L1 ASSAY TO SELECT PATIENTS WITH METASTATIC NSCLC WHO ARE POTENTIAL CANDIDATES FOR TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS
Sheppard B1, Ahlsten M1, Paolini D2, Xenakis J3, Zhang W3
1Roche Tissue Diagnostics, Tucson, AZ, USA, 2Roche Diagnostics S.p.A., Monza, AZ, USA, 3WG Group, New York, NY, USA

PMD23
A23
ECONOMIC ANALYSIS OF THE LUTONIX® 035 DRUG COATED BALLOON PTA CATHETER FOR THE TREATMENT OF VASCULAR ACCESS STENOSIS IN PATIENTS WITH ARTERIOVENOUS FISTULAS
Barclay B1, Delatore P2, Ferko N3, Hollmann S3
1C.R. Bard, Inc., Tempe, AZ, USA, 2CR Bard Inc., Murray Hill, NJ, USA, 3Cornerstone Research Group Inc., Burlington, ON, Canada

PMD24
A24
BUDGET IMPACT ANALYSIS FOR SWITCHING FROM MANUAL TO PRE-FILLED SYRINGES FOR CATHETER MAINTENANCE
Bal V1, Culiner J1, O'Hara M2, Khangulov VS2
1BD Medical, Franklin Lakes, NJ, USA, 2Boston Strategic Partners, Inc., Boston, MA, USA

PMD25
A25
BUDGET IMPACT OF A SUPRA-CILIARY MICRO-STENT IN BOTH STAND-ALONE SURGERY AND IN COMBINATION WITH CATARACT SURGERY FOR PRIMARY OPEN-ANGLE GLAUCOMA FROM A UK SECONDARY CARE PERSPECTIVE
Barton K1, Au L2, Bouchet C3, Le Brenne A4, Morris L5, Patel K6, Falla E6, Kowal S7, Ferrufino C8
1Moorfields NHS Foundation Trust, London, UK, 2Central Manchester University NHS Foundation Trust, Manchester, UK, 3Alcon Laboratories, Inc, Fort Worth, TX, USA, 4Alcon Laboratories, Inc, Camberley, UK, 5Alcon Laboratories, Fort Worth, TX, USA, 6QuintilesIMS, London, UK, 7QuintilesIMS, Seattle, WA, USA, 8QuintilesIMS, Fairfax, VA, USA

PMD26
A26
CLINICAL AND COST IMPACT OF A NOVEL NON-INVASIVE APPROACH FOR THE TREATMENT OF CERVICAL DYSPLASIA FROM A US PAYER PERSPECTIVE
Einstein MH1, Gavaghan M2, Infante K3
1Rutgers New Jersey Medical School, Newark, NJ, USA, 2GfK, Waltham, MA, USA, 3GfK, New York, NY, USA

PMD27
A27
DO BUDGET IMPACT ANALYSES FOR SCREENING OF CANCERS FOLLOW INTERNATIONAL GUIDELINES? A SYSTEMATIC REVIEW
Jahn B1, Todorovic J1, Bundo M1, Sroczynski G1, Conrads-Frank A1, Rochau U1, Chhatwal J2, Mauskopf J3, Siebert U4
1Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria, 2Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA, 3RTI Health Solutions, RTI International, Durham, NC, USA, 4UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria. Department of Health Policy and Management, Harvard T.H. Chan School of Public Health. Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA

PMD28
B1
A BUDGET IMPACT ANALYSIS OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN FRANCE
Goodall G, Candolfi P, Sohlberg A
Edwards Lifesciences, Nyon, Switzerland

PMD29
B2
BUDGET IMPACT ANALYSIS OF SUPRA-CILIARY MICROSTENT DEVICE UTILIZATION IN PRIMARY OPEN ANGLE GLAUCOMA PATIENTS IN A SPANISH HOSPITAL OUTPATIENT SETTING
Ferrufino C1, Kowal S2, Morris L3, Patel K4, Falla E4, Bouchet C5
1QuintilesIMS, Fairfax, VA, USA, 2QuintilesIMS, Seattle, WA, USA, 3Alcon Laboratories, Fort Worth, TX, USA, 4QuintilesIMS, London, UK, 5Alcon Laboratories, Inc, Fort Worth, TX, USA

PMD30
B3
A BUDGET IMPACT ANALYSIS OF INCREASING PERITONEAL DIALYSIS (PD) IN ADULTS EXPERIENCING UNPLANNED START DIALISYS (URGENT START) IN BRAZIL
Tannus G1, Sansone D2, Farah D3, Ramirez MG4, Fonseca M3
1Axia.Bio Life Sciences International, Miami, FL, USA, 2AxiaBio, São Paulo, Brazil, 3Federal University of São Paulo, São Paulo, Brazil, 4Baxter, Mexico city, Mexico

PMD31
B4
ALK IMMUNOHISTOCHEMICAL TEST IN THE DETECTION OF PATIENTS AFFECTED BY ALK+ NON-SMALL CELL LUNG CANCER: CLINICAL AND BUDGET IMPACT
Paolini D1, Tiseo M2, Dionisi M3, Demma F4, Furneri G4, Akkermans M5, Marchetti A6
1Roche Diagnostics S.p.A., Monza, AZ, USA, 2Azienda Ospedaliera - Universitaria di Parma, Parma, Italy, 3Roche Diagnostics S.p.A., Monza, Italy, 4EBMA Consulting SRL, Melegnano, Italy, 5Roche Diagnostics International Ltd, Rotkreuz, Switzerland, 6University of Chieti, Chieti, Italy

PMD32
B5
BUDGET IMPACT ANALYSIS (BIA) OF MECHANICAL THROMBECTOMY IN ACUTE PHASE OF ISCHEMIC STROKE (AIS)
Pochopien M, Fundament T, Niesyczynski G, Lembas A, Plisko R
HTA Consulting, Krakow, Poland

PMD33
B6
ECONOMIC ANALYSIS OF THE USE OF NON-INVASIVE PRENATAL TEST (NIPT) FOR PRENATAL SCREENING OF TRISOMY 21, 18, 13 IN PREGNANT WOMEN
Paolini D1, Camurri L2, Dionisi M3, Speranza G3, Prefumo F4
1Roche Diagnostics S.p.A., Monza, AZ, USA, 2Medi Saluser, Parma, Italy, 3Roche Diagnostics S.p.A., Monza, Italy, 4Spedali Civili Brescia, Brescia, Italy

PMD34
B7
CHANGES IN ACUTE MEDICATION COST OBSERVED IN CLUSTER HEADACHE PATIENTS TREATED WITH SPHENOPALATINE GANGLION (SPG) STIMULATION: A U.K. NHS-SPECIFIC ANALYSIS BASED ON DATA FROM THE PATHWAY R1 REGISTRY
Pietzsch JB1, Lund N2, Weber SA3, Gaul C4
1Wing Tech Inc., Irvine, CA, USA, 2University of Copenhagen, Glostrup, Denmark, 3Cellogic GmbH, Berlin, Germany, 4Migräne und Kopfschmerzklinik Königstein, Königstein im Taunus, Germany

PMD35
B8
HEALTHCARE COSTS OF PATIENTS WITH ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN BELGIUM: A RETROSPECTIVE DATA COLLECTION AND ANALYSIS
Strens D1, Schoemans H2, Renard M2
1Realidad bvba, Grimbergen, Belgium, 2UZ Leuven, Leuven, Belgium

PMD36
WITHDRAWN

PMD37
B9
COST-EFFECTIVENESS ANALYSIS OF PRIMARY HPV SCREENING WITH DUAL-STAIN CYTOLOGY TRIAGE IN THE CERVICAL CANCER SCREENING PROGRAM OF BELGIUM
Vandeweyer K1, Tjalma W2
1Roche Diagnostics Belgium, Brussels, Belgium, 2Antwerp University Hospital, Edegem, Belgium

PMD38
B10
MULTIPLATFORM TUMOR PROFILING DELIVERS VALUE BASED HEALTH CARE IN REFRACTORY CANCER PATIENTS
Russell KJ1, Dean A2, Muckle G3, Hussain T3, Hernandez A1, Voss A1, Spetzler D4
1Caris Life Sciences, Basel, Switzerland, 2St John of God Hospital, Subiaco, Australia, 3Champions Oncology, Inc, London, UK, 4Caris Life Sciences, Phoenix, AZ, USA

PMD39
B11
ECONOMIC EFFECTIVENESS OF THE ATTUNE® KNEE SYSTEM - ANALYSIS OF REAL WORLD HOSPITAL LENGTH OF STAY AND INCIDENCE OF EARLY COMPLICATIONS
Mantel J1, Corso KA2, Wei D2, Holy CE2, Muehlendyck C3, Jayakumar P4, Higgins M5, Westbrook A5
1DePuy Synthes, Leeds, UK, 2Johnson & Johnson, New Brunswick, NJ, USA, 3Johnson & Johnson Medical GmbH, Norderstedt, Germany, 4Johnson and Johnson Medical Devices, London, UK, 5Nottingham University Hospital, Nottingham, UK

PMD40
B12
THE RESOURCE AND COST CONSEQUENCES OF USING ANTIBIOTIC COATED INTRAMEDULLARY NAILS COMPARED TO NON-COATED NAILS IN OPEN TIBIA FRACTURES ACROSS FOUR EUROPEAN CENTRES
Taylor H1, Wolf S2, Paparouni K2
1Johnson & Johnson Medical Limited, Leeds, UK, 2Synthes GmbH, Zuchwil, Switzerland

PMD41
B13
COSTS ANALYSIS OF NOVEL FLASH GLUCOSE MONITORING TECHNOLOGY IN ADULTS WITH TYPE 2 DIABETES MELLITUS (T2DM) UNDER INSULIN TREATMENT IN SPAIN
Khan-Mirón A, Sánchez-Iriso E, Cabases-Hita JM
Universidad Pública de Navarra, Pamplona, Spain

PMD42
B14
TREATMENT CHOICES BASED ON MULTIPLATFORM PROFILING PLATFORM, UNLIKE THOSE WITH SEQUENCING ALONE, DO NOT CAUSE A COST EXPLOSION IN REFRACTORY CANCER PATIENTS
Russell KJ1, Janssens J2, Dean A3, Hernandez A1, Voss A1
1Caris Life Sciences, Basel, Switzerland, 2University Hasselt, Hasselt, Belgium, 3St John of God Hospital, Subiaco, Australia

PMD43
B15
COMPARISON OF U.S. HOSPITAL COSTS BETWEEN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) AND SURGICAL AORTIC VALVE REPLACEMENT (SAVR)
Meduri C1, Chung JK2, Gaffney JC2, Henley S2, Williams JM2, Gada H3
1Marcus Heart Valve Center, Piedmont Heart Institute, Atlanta, GA, USA, 2Medtronic, Mounds View, MN, USA, 3PinnacleHealth System, Wormleysburg, PA, USA

PMD44
B16
HOSPITAL COSTS ASSOCIATED WITH DEDICATED VASCULAR ENDOPROSTHESIS VERSUS PROSTHETIC BYPASS IN POPLITEAL ARTERY ANEURYSM TREATMENT IN FRANCE
de Léotoing L1, Jouaneton B1, Fernandes J2, Vainchtock A3, Hanoka S4
1HEVA, LYON, France, 2Oc-Santé, Montpellier, France, 3HEVA, Lyon, France, 4W.L. Gore & Associates, Paris, France

PMD45
B17
USE OF THE IMS CORE DIABETES MODEL (CDM) IN A LONG-TERM PROJECTED HEALTH ECONOMIC COMPARISON OF CSII AND MDI TREATMENTS OF TYPE 1 DIABETES (T1D) IN A NEWLY-DIAGNOSED POPULATION OF PAEDIATRIC PATIENTS.
Ridyard CH1, Blair J2, Hughes DA1, on behalf of the SCIPI Trial Investigators .3
1Bangor University, Bangor, UK, 2Alder Hey Children's NHS Foundation Trust, Liverpool, UK, 3Clinical Trials Research Centre, Liverpool, UK

PMD46
B18
A CRITICAL QUALITY APPRAISAL OF STUDIES ESTIMATING THE COST OF RADIOTHERAPY
Defourny N1, Lievens Y2, Dunscombe P3, Monnet J4, Grau C5, Perrier L4
1European Society for Radiation Oncology, Brussels, Belgium, 2Ghent university, Ghent, Belgium, 3University of Calgary, Calgary, AB, Canada, 4Cancer Centre Léon Bérard, Lyon, France, 5Aarhus University, Aarhus, Denmark

PMD47
B19
CLINICAL AND ECONOMIC OUTCOMES OF MICROINVASIVE GLAUCOMA SURGERY (MIGS) WITH STENTS IN PATIENTS WITH MILD-TO-MODERATE OR REFRACTORY GLAUCOMA IN SPAIN
Belda J1, Patel V2, Aceituno S3, Cantu M4, Gicquel G5, Botteman M2, Falvey H4
1Hospital of Torrevieja, Alicante, Spain, 2Pharmerit International, Bethesda, MD, USA, 3Outcomes'10, Castellon de la Plana, Spain, 4Glaukos Corporation, San Clemente, CA, USA, 5Glaukos Corporation, Paris, France

PMD48
B20
MICRO ECONOMIC ANALYSIS OF THE COPD EXACERBATIONS AND HOSPITALIZATIONS BURDEN ON THE HEALTH CARE SYSTEM IN BULGARIA
Tachkov K1, Dimitrova M1, Mitov K1, Savova A1, Kamusheva M1, Dimitrov JS2
1Medical University-Sofia, Faculty of Pharmacy, Sofia, Bulgaria, 2Medical University of Sofia, Sofia, Bulgaria

PMD49
B21
REDUCED NEEDLESTICK INJURIES AND HBV INFECTIONS IN CHINESE HEALTHCARE WORKERS FROM BLUNT-TIP SUTURE NEEDLES IN CESAREAN SECTIONS: A MARKOV SIMULATION
Kong L1, Zheng Y2, Lee SH3
1Johnson & Johnson, Shanghai, China, 2Johnson & Johnson, Ethicon, Shanghai, China, 3Johnson & Johnson Medical, Asia Pacific, Singapore, Singapore

PMD50
B22
POSTERIOR CAPSULE OPACIFICATION AFTER CATARACT EXTRACTION AND RELATED HEALTHCARE COSTS IN GERMANY – A CLAIMS DATA ANALYSIS ON THE IMPACT OF THE IMPLANTED TYPE OF INTRAOCULAR LENSES
Schindler CJ, Kossack N, Weinhold I, Häckl D
WIG2 Institute for Health Economics and Health System Research, Leipzig, Germany

PMD51
B23
CLINICAL AND ECONOMIC BENEFIT OF UPPER AIRWAY STIMULATION FOR OBSTRUCTIVE SLEEP APNEA IN THE GERMAN SETTING
Pietzsch JB1, Weschenfelder A2, Randerath W3, Steffen A4, Liu S1, Geisler BP1, Wasem J2, Biermann J2
1Wing Tech Inc., Irvine, CA, USA, 2Universität Duisburg-Essen, Essen, Germany, 3Bethanien Hospital Solingen, Solingen, Germany, 4University Hospital Schleswig-Holstein, Lübeck, Germany

PMD52
B24
THE COST-EFFECTIVENESS OF DETECTING ARRHYTHMIAS WITH INSERTABLE CARDIAC MONITORS (ICM) IN TURKEY
Özdemir Saltık Z1, Tsintzos S2, Diamantopoulos A3, Quiroz M4, Scott RA5
1Medtronic Turkey, Instabul, Turkey, 2Medtronic International Trading Sarl, Tolochenaz, Switzerland, 3Symmetron Limited, Elstree, UK, 4Medtronic Plc, Mounds View, MN, USA, 5Medtronic, Mounds View, MN, USA

PMD53
B25
REMOTE THERAPY MANAGEMENT OF PATIENTS ON AUTOMATED PERITONEAL DIALYSIS DEMONSTRATES COST SAVINGS IN GERMANY AND ITALY
Makhija D1, McLeod K2, Sloand JA1, Gellens ME1, Alscher MD3, Becker S4, D’Alonzo S5
1Baxter Healthcare Corporation, Deerfield, IL, USA, 2Xcenda LLC, Palm Harbor, FL, USA, 3Robert-Bosch Hospital, Stuttgart, Germany, 4University Hospital Essen, Essen, Germany, 5Catholic University of the Sacred Heart, Rome, Italy

PMD54
B26
COST CONSEQUENCE ANALYSIS OF DIFFERENT GENE MUTATION TESTING MODALITIES FOR BRAF V600E MUTATION IN ADVANCED NON-SMALL CELL LUNG CANCER USING A DECISION ANALYTIC MODEL
Dalal A1, Zhou Z2, Tang W3, Ricculli ML3, Guerin A4, Sasane M1, Wu K1, Culver K1, Otterson G5, Pennell N6
1Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 2Analysis Group, Inc., London, UK, 3Analysis Group, Inc., Boston, MA, USA, 4Analysis Group, Inc., Montreal, QC, Canada, 5The Ohio State University, Columbus, OH, USA, 6Cleveland Clinic, Cleveland, OH, USA

PMD55
B27
COST-CONSEQUENCES OF USING FLUCICLOVINE (F 18) FOR THE DIAGNOSIS AND STAGING OF RECURRING PROSTATE CANCER
Jensen I1, Cyr P1, Gauden D2
1Precision Health Economics, Boston, MA, USA, 2Blue Earth Diagnsotics, Oxford, UK

PMD56
C1
WOUND MANAGEMENT IN DIABETIC FOOT ULCER (DFU) - INCREMENTAL COST-ANALYSIS OF TREATING DIABETIC NEUROPATHIC FOOT LESIONS WITH ADJUNCT HEMOGLOBIN CONTACT SPRAY IN GERMANY
Brüggenjürgen B1, Eberlein T2, Hunt S3
1Steinbeis University Berlin, Berlin, Germany, 2Dermatology Expert Office, Leipzig, Germany, 3Valens Medical Partnership, Berwick, UK

PMD57
C2
A COST CONSEQUENCES ANALYSIS OF THE HUMAN BODY POSTURIZER IN ITALY
Belfiore P1, D'Ausilio A2, Aiello A2, Toumi M3, Scaletti A1, Frau A4, Ripani M4, Romano Spica V4, Liguori G1
1University of Naples Parthenope, Naples, Italy, 2Creativ Ceutical, Milan, Italy, 3Aix-Marseille University, Marseille, France, 4University of Rome “Foro italico”, Rome, Italy

PMD58
C3
CONTINUOUS SUBCUTANEOUS INFUSION VERSUS MULTIPLE DOSE INJECTION OF INSULIN FOR NEWLY-DIAGNOSED T1D PAEDIATRIC PATIENTS: A COST-UTILITY ANALYSIS
Ridyard CH1, Blair J2, Hughes DA1, on behalf of the SCIPI Trial Investigators .3
1Bangor University, Bangor, UK, 2Alder Hey Children's NHS Foundation Trust, Liverpool, UK, 3Clinical Trials Research Centre, Liverpool, UK

PMD59
C4
COST-EFFECTIVENESS OF PREOPERATIVE MRI IN DUCTAL CARCINOMA IN SITU OF THE BREAST
Kandel M, Dunant A, Balleyguier C, Bonastre J
Gustave Roussy, Villejuif, France

PMD60
C5
COST-EFFECTIVENESS OF THE SUFENTANIL SUBLINGUAL TABLET SYSTEM VS IV PCA MORPHINE FOR THE TREATMENT OF ACUTE MODERATE TO SEVERE POST-OPERATIVE PAIN IN IRELAND
Mistry R1, Mbanya Z2, Liedgens H3
1PAREXEL International, London, UK, 2Axis Healthcare Consulting Ltd., Galway, Ireland, 3Grünenthal GmbH, Aachen, Germany

PMD61
C6
PORT CATHETER VERSUS PERIPHERALLY INSERTED CENTRAL CATHETER FOR ADJUVANT CHEMOTHERAPY IN BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS
Duclos M1, Orsini C1, Fuss D1, Dumet A1, Vermeulin T2, Lucas M2, Lefebvre L1, Clatot F1, Daouphars M1
1Centre Henri Becquerel, ROUEN, France, 2University Hospital Charles Nicolle, ROUEN, France

PMD62
C7
MOBILE CARDIAC MONITORIZATION IS A COST-EFFECTIVE TOOL FOR THE DIAGNOSIS AND MANAGEMENT OF ATRIAL FIBRILLATION COMPARED TO HOLTER: A COST EFFECTIVENESS STUDY IN TURKEY
Sharaf A1, Ammar H1, Kockaya G1, Yenilmez FB2, Akagunduz Akgul D3
1CarthaGenetics, Pully, Switzerland, 2Akıl Consultancy, London, UK, 3Turkiye Klinikleri, Ankara, Turkey

PMD63
C8
COST-EFFECTIVENESS OF A FLASH GLUCOSE MONITORING SYSTEM BASED ON REAL-WORLD USAGE FOR TYPE 1 DIABETES (T1DM) PATIENTS USING INTENSIVE INSULIN: A SWEDISH PERSPECTIVE
Bilir SP1, Wehler EA2, Hellmund R3, Munakata J1
1QuintilesIMS, San Francisco, CA, USA, 2QuintilesIMS, Plymouth Meeting, PA, USA, 3Abbott Diabetes Care, Alameda, CA, USA

PMD64
C9
WITHDRAWN

PMD65
C10
COST EFFECTIVENESS OF URBAN BREAST CANCER SCREENING PROGRAMME IN CHINA
Sun L, Yang L
Peking University, Beijing, China

PMD66
C11
COST-EFFECTIVENESS ANALYSIS OF COBLATION TECHNOLOGY VS. MECHANICAL DEBRIDEMENT WITH A SHAVER IN THE TREATMENT OF KNEE CARTILAGE LESIONS- A SPANISH PAYER PERSPECTIVE.
Adeyemi A1, Nherera L2, Trueman P3, Cano J4
1Smith & Nephew, Andover, MA, USA, 2Smith & Nephew, Watford Hertfordshire, MA, UK, 3Smith & Nephew, Watford, UK, 4Smith & Nephew, Barcelona, Spain

PMD67
C12
COST EFFECTIVENESS OF BARIATRIC SURGERY IN TURKEY: FROM A LONG-TERM PERSPECTIVE
Tatar M1, Şentürk A1, Turgut CG2, Tandoğan A2, Bektaş T2
1Polar Health Economics & Policy Consultancy, Ankara, Turkey, 2Johnson & Johnson, Istanbul, Turkey

PMD68
C13
THE POTENTIAL VALUE OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN ACTIVE SURVEILLANCE OF MEN WITH LOW-RISK PROSTATE CANCER: A COST-EFFECTIVENESS MODELING STUDY
Patel S1, Rongen JJ1, Boltyenkov A2, Rovers MM1
1Radboudumc, Nijmegen, The Netherlands, 2Siemens Healthcare GmbH, Erlangen, Germany

PMD69
C14
CLINICAL AND ECONOMIC VALUE OF DEVICE-BASED DETECTION OF ATRIAL FIBRILLATION IN PATIENTS WITH CRYPTOGENIC STROKE
Maervoet J1, Bossers N2, Borge Jr RP3, Schöllbauer V4, van Engen A2, Smala A5
1QuintilesIMS, Vilvoorde, Belgium, 2QuintilesIMS, Hoofddorp, The Netherlands, 3Abington Memorial Hospital, Abington, PA, USA, 4BIOTRONIK SE & Co KG, Berlin, Germany, 5Biotronik SE & Co KG, Berlin, Germany

PMD70
C15
COST EFFECTIVENESS OF PENTARAY HIGH DENSITY MAPPING CATHETER IN TREATMENT OF VENTRICULAR TACHYCARDIA IN TURKEY
Tatar M1, Tuna E1, Şentürk A1, Turgut CG2, Erdoğan G2, Sezginer G2, Akkurt E2
1Polar Health Economics & Policy Consultancy, Ankara, Turkey, 2Johnson & Johnson, Istanbul, Turkey

PMD71
C16
ECONOMIC EVALUATION OF CEREBRAL OXIMETRY MONITORING IN CAROTID ENDARTERECTOMY : THE EMOCAR RANDOMIZED CONTROLLED TRIAL (MAY 2011 - APRIL 2016)
Cabout E, Kabeshova A, Launois R
REES France, Paris, France

PMD72
C17
ECONOMIC EVALUATION OF FLASH GLUCOSE MONITORING COMPARED TO SELF - MONITORING OF BLOOD GLUCOSE FOR THE MANAGEMENT OF PATIENTS RECEIVING INTENSIVE INSULIN WITH DIABETES TYPE 1 AND TYPE 2 IN GREECE
Vellopoulou K1, Kourlaba G1, Doupis J2, Maniadakis N3
1EVROSTON LP, Athens, Greece, 2Athens Medical Center, P. Faliro, Greece, 3National School of Public Health, Athens, Greece

PMD73
C18
EVALUATION OF THE LONG-TERM COST-EFFECTIVENESS OF REAL TIME CONTINUOUS GLUCOSE MONITORING (RTCGM) VERSUS SELF MONITORING OF BLOOD GLUCOSE (SMBG) ALONE IN TYPE 1 DIABETES FROM THE SWEDISH SOCIETAL PERSPECTIVE
Klinkenbijl B1, Jendle J2, Chaugule S3, Graham C4
1Dexcom, Inc., Essertines sur Rolle, Switzerland, 2Örebro University, Örebro, Sweden, 3Dexcom, Inc, San Diego, CA, USA, 4Dexcom, Inc., San Diego, CA, USA

PMD74
C19
THE COST-EFFECTIVNESS ANALYSIS OF THE LATENT TUBERCULOSIS INFECTION SCREENING FOR ADULTS 40 YEARS OLD IN SOUTH KOREA.
Yang J1, Suh J2, Tchoe H3, Shin S3
1National Evidence-based Healthcare Collaborating Agency (NECA), Seoul, Korea, Republic of (South), 2National Evidence based Healthcare Collaborating Agency, Seoul, Korea, Republic of (South), 3National Evidence based Health-care Collaborating Agency, Seoul, Korea, Republic of (South)

PMD75
C20
ECONOMIC EVALUATION OF NEONATAL SCREENING FOR CONGENITAL HYPOTHYROIDISM
Lang H1, Lin W1, Niu D2
1National Yang-Ming University, Taipei, Taiwan, 2Taipei Veterans General Hospital, Taipei, Taiwan

PMD76
C21
COST-EFFECTIVENESS OF A SUPRACILIARY MICRO-STENT GLAUCOMA IMPLANT COMBINED WITH CATARACT SURGERY IN MANAGEMENT OF PRIMARY OPEN-ANGLE GLAUCOMA (POAG) FROM THE CANADIAN PAYER PERSPECTIVE
Podbielski DW1, Bilir SP2, Kowal S3, Bouchet C4, Morris L5, Gill R6, Ahmed II7
1Prism Eye Institute, Mississauga, ON, Canada, 2QuintilesIMS, San Francisco, CA, USA, 3QuintilesIMS, Seattle, WA, USA, 4Alcon Laboratories, Inc, Fort Worth, TX, USA, 5Alcon Laboratories, Fort Worth, TX, USA, 6Alcon Canada, Inc, Mississauga, ON, Canada, 7University of Toronto, Mississauga, ON, Canada

PMD77
C22
COST-EFFECTIVENESS OF A DIRECT ASPIRATION FIRST PASS TECHNIQUE (ADAPT) FOR THROMBECTOMY REVASCULARIZATION OF LARGE VESSEL OCCLUSION IN ACUTE ISCHEMIC STROKE (FRENCH HEALTH MINISTRY PRME 16-0020)
Soilly AL1, Kossi DS2, Leherle A1, Orng E1, Labreuche J3, Blanc R1, Piotin M1, Lapergue B4, Baffert S1
1Rothschild Foundation, Paris, France, 2Fondation Ophtalmologique Adolphe de Rothschild, Paris, France, 3University of Lille, Lille, France, 4Hôpital Foch, University Versailles Saint Quentin en Yvelynes, Suresnes, France

PMD78
C23
COST-EFFECTIVENESS OF EASYPOD™ DEVICE VERSUS OTHER SOMATOTROPIN DELIVERY TECHNIQUES IN EGYPT IN TREATMENT OF GROWTH HORMONE DEFICIENCY
Elashmawy AA1, Anwar GM1, Elsedfy H2, El Kholy MS2, Hana MA1, Hafez MF1, Hassan MM1, Salem M2, Salah Metwaly N1, Amr NH2, Hamza RT2, Tawfik S3, Abdelghaffar S1, Rafik R4, Raed M5, Anan I5
1Cairo University, Cairo, Egypt, 2Ain Shams University, Cairo, Egypt, 3Military Medical Academy, cairo, Egypt, 4Merck, Cairo, Egypt, 5Accsight, Cairo, Egypt

PMD79
C24
THE COMPARATIVE PHARMACOECONOMIC ANALYSIS OF USING ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM FOR PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI)
Krysanova V1, Krysanov I2, Ermakova V1
1Sechenov University, Moscow, Russia, 2Institute of Medical and Social Technologies, Moscow National University of Food Production, Moscow, Russia

PMD80
C25
COST-UTILITY ANALYSIS OF A NOVEL BREATH-TRIGGERED AEROSOL INHALER WHICH HAS BEEN DESIGNED TO REDUCE THE CRITICAL HANDLING ERROR OF INSUFFICIENT INSPIRATORY EFFORT
Forster R1, Ratcliffe A2, Lewis M2, Crossley A2, Lopez Bastida J3, Dunlop W1
1Mundipharma International Ltd, Cambridge, UK, 2Adelphi Values Ltd, Bollington, UK, 3Universidad Castilla-La Mancha, Toledo, Spain

PMD81
C26
COST EFFECTIVENESS OF UNIVERSAL NEONATAL HEARING SCREENING WITH OTOACOUSTIC EMISSIONS AND/OR AUTOMATED AUDITORY BRAINSTEM RESPONSE, FOR THE DETECTION OF BILATERAL CONGENITAL HEARING LOSS AND EARLY TREATMENT, IN NEWBORNS WITHOUT RISK FACTORS, IN COLOMBIA
Medina Torres YA1, Diaz Rojas JA2, Gamboa Garay OA3
1Instituto para la Evaluación de la Calidad y Atención en Salud-IECAS, Bogotá, Colombia, 2Universidad Nacional de Colombia, Bogotá D.C., Colombia, 3Universidad de la Sabana, Bogotá, Colombia

PMD82
C27
COST-EFFECTIVENESS OF INSULIN PUMPS VERSUS MULTIPLE DAILY INSULIN (MDI) INJECTION IN TYPE 1 DIABETES IN INDIA FROM SOCIETAL PERSPECTIVE
Pandey P, Pandey R
SIRO Clinpharm Pvt Ltd, Maharashtra, India

PMD83
D1
COST-EFFECTIVENESS ANALYSIS OF NEONATAL SCREENING WITH PULSE OXIMETRY FOR THE DETECTION OF CRITICAL CONGENITAL HEART DISEASE IN COLOMBIA, 2017.
Londoño D1, Taborda A1, Domínguez MT2, Sandoval NS2, Troncoso GT2, Fonseca AF2, Aranguren CA2, Novoa LN2, Dennis RJ2
1Fundación Santa Fé de Bogotá, Bogotá, Colombia, 2Fundación Cardioinfantil, Bogotá, Colombia

PMD84
D2
COST EFFECTIVENESS OF DURAGRAFT AS A VEIN GRAFT TREATMENT IN CORONARY ARTERY BYPASS GRAFTING IN TURKEY
Tatar M1, Şentürk A1, Nogueira E2
1Polar Health Economics & Policy Consultancy, Ankara, Turkey, 2Qmed Consulting, Køge, Denmark

PMD85
D3
COST EFFECTIVENESS OF ULTRASOUND SCREENING, CANCER PATIENTS, TO DETECT ASYMPTOMATIC THROMBOSIS
Kourlaba G1, Gourzoulidis G1, Rasmussen E2, Kontodimas S3, Maniadakis N4
1Evroston LP, Athens, Greece, 2LEO Pharma, København, Denmark, 3LEO Pharma Hellas, Athens, Greece, 4National School of Public Health, Athens, Greece

PMD86
D4
COST-EFFECTIVENESS OF A FLASH GLUCOSE MONITORING SYSTEM BASED ON REAL-WORLD USAGE FOR TYPE 2 DIABETES (T2DM) PATIENTS USING INTENSIVE INSULIN: A SWEDISH PERSPECTIVE
Bilir SP1, Wehler EA2, Hellmund R3, Munakata J1
1QuintilesIMS, San Francisco, CA, USA, 2QuintilesIMS, Plymouth Meeting, PA, USA, 3Abbott Diabetes Care, Alameda, CA, USA

PMD87
D5
ASSESSING THE COST-EFFECTIVENESS OF THE MANCHESTER ACUTE CORONARY SYNDROME (MACS) DECISION-AID: A FEASIBILITY STUDY
Thompson AJ1, Lecky F2, Body R3
1The University of Manchester, Manchester, UK, 2Salford Royal NHS Foundation Trust, Salford, UK, 3Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK

PMD88
D6
COST-EFFECTIVENESS OF HIGH-THROUGHPUT, NON-INVASIVE PRENATAL TESTING FOR FETAL RHESUS D STATUS
Saramago P1, Palmer S1, Griffin S2
1University of York, Heslington, York, UK, 2University of York, York, UK

PMD89
D7
COST EFFICIENCY ANALYSIS OF A NEW ARRHYTHMIA DETECTION ALGORITHM IN A MINIATURIZED INSERTABLE CARDIAC MONITOR
Quiroz M1, Rogers J2, Ousdigian K3, Koehler J3
1Medtronic Plc, Mounds View, MN, USA, 2Scripps Clinic, John R. Anderson V Medical Pavilion, La Jolla, CA, USA, 3Medtronic, Mounds View, MN, USA

PMD90
D8
COST-MINIMIZATION ANALYSIS OF HPV 16/18 GENOTYPING TEST VERSUS HPV REFLEX GENOTYPING FOR CERVICAL CANCER SCREENING
Skroumpelos A1, Agorastos T2, Chatzistamatiou K2, Poulios N3, Kyriopoulos J4
1Roche (Hellas) S.A., Athens, Greece, 2Aristotle University, Thessaloniki, Greece, 3Roche Molecular Systems, Inc., Pleasanton, CA, USA, 4National School of Public Health, Athens, Greece

PMD91
D9
INSERTABLE CARDIAC MONITOR VERSUS STANDARD OF CARE FOR DETECTION OF ATRIAL FIBRILLATION IN PATIENTS FOLLOWING CRYPTOGENIC STROKE: A DUTCH COST-EFFECTIVENESS ANALYSIS
Quiroz M1, Wolff C2, Eggington S2
1Medtronic Plc, Mounds View, MN, USA, 2Medtronic International Trading Sarl, Tolochenaz, Switzerland

PMD92
D10
THE COST-EFFECTIVENESS OF TAVI IN INTERMEDIATE RISK PATIENTS IN FRANCE
Goodall G1, Candolfi P1, Zemanova B2, Sohlberg A1
1Edwards Lifesciences, Nyon, Switzerland, 2Edwards Lifescience, irvine, CA, USA

PMD93
D11
COST-EFFECTIVENESS ANALYSIS OF STEREOTAXIC EEG (SEEG) AS A PREOPERATIVE DIAGNOSTIC PROCEDURE IN EPILEPSY SURGERY.
Kovacs S, Tóth M, Boncz I, Zemplenyi A
University of Pécs, Pécs, Hungary

PMD94
D12
COST-EFFECTIVENESS OF PET/CT IN PRE-OPERATIVE STAGING OF PANCREATIC CANCER: AN ECONOMIC EVALUATION OF THE PET-PANC COHORT STUDY
Plumpton CO1, Ghaneh P2, Lloyd-Williams H1, Yeo ST1, Edwards RT1
1Bangor University, Bangor, UK, 2University of Liverpool, Liverpool, UK

PMD95
D13
COST-EFFECTIVENESS ANALYSIS OF MECHANICAL THROMBECTOMY IN ACUTE PHASE OF ISCHEMIC STROKE (AIS)
Pochopien M, Niesyczynski G, Gorecki M, Plisko R
HTA Consulting, Krakow, Poland

PMD96
D14
THE COST-EFFECTIVENESS OF TAVI IN INOPERABLE AND HIGH RISK PATIENTS IN FRANCE
Goodall G1, Zemanova B2, Candolfi P1, Sohlberg A1
1Edwards Lifesciences, Nyon, Switzerland, 2Edwards Lifescience, irvine, CA, USA

PMD97
D15
A COST-UTILITY ANALYSIS OF ARTIFICIAL URINARY SPHINCTER VERSUS ADVANCE MALE SLING IN POST PROSTATECTOMY STRESS URINARY INCONTINENCE: A CANADIAN HEALTHCARE PERSPECTIVE
Nazha S1, Shamout S2, Prevost N1, Campeau L2, Dragomir A1
1McGill University Health Centre, Montreal, QC, Canada, 2Division of Urology, Montreal, QC, Canada

PMD98
D16
INTEGRATING NOVEL SCREENING METHODS FOR PROSTATE CANCER, COST-UTILITY INTERVENTIONS
Dragomir A1, Bonnevier E2, Kassouf W3, Aprikian A3, Palenius E2, Nazha S3
1McGill University, Montreal, QC, Canada, 2Lund University, Lund, Sweden, 3McGill University Health Centre, Montreal, QC, Canada

PMD99
D17
COMPARISON OF UTILITY COST IN THREE COMMERCIALLY AVAILABLE PRECISION MEDICINE APPROACHES IN ONCOLOGY
Russell KJ1, Janssens J2, Dean A3, Hernandez A1, Voss A1
1Caris Life Sciences, Basel, Switzerland, 2University Hasselt, Hasselt, Belgium, 3St John of God Hospital, Subiaco, Australia

PMD100
D18
COST-UTILITY OF NOVEL TESTS AFTER A NEGATIVE PROSTATE BIOPSY
Dragomir A1, Palenius E2, Aprikian A3, Kassouf W3, Bonnevier E2, Nazha S3
1McGill University, Montreal, QC, Canada, 2Lund University, Lund, Sweden, 3McGill University Health Centre, Montreal, QC, Canada

PMD101
D19
COST-UTILITY OF LIQUID CHROMATOGRAPHY -TANDEM MASS SPECTROMETRY (LC-MS/MS)-BASED URINE ANALYSES TO IMPROVE ADHERENCE TO ANTIHYPERTENSIVE TREATMENT
van Schoonhoven AV1, van Asselt AD1, Gupta P2, Patel P2, Postma MJ1
1University of Groningen, Groningen, The Netherlands, 2University of Leicester, Leicester, UK

PMD102
D20
PATTERNS IN WORKING DAYS LOST BY PARENTS OF CHILDREN NEWLY-DIAGNOSED WITH TYPE 1 DIABETES (T1D).
Ridyard CH1, Blair J2, Hughes DA1, on behalf of the SCIPI Trial Investigators .3
1Bangor University, Bangor, UK, 2Alder Hey Children's NHS Foundation Trust, Liverpool, UK, 3Clinical Trials Research Centre, Liverpool, UK

PMD103
D21
IMPACT OF ADENOMA SURVEILLANCE GUIDELINES ON THE FUTURE DEMAND OF COLONOSCOPIES ASSOCIATED TO A POPULATION-BASED COLORECTAL CANCER SCREENING PROGRAM
Comas M1, Andreu M2, Juárez D2, Louro J1, Bessa X2, Buron A1, Castells X1
1IMIM (Hospital del Mar Medical Research Institute); Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Barcelona, Spain, 2IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain

MEDICAL DEVICES/DIAGNOSTICS - Patient-Reported Outcomes & Patient Preference Studies
PMD104
D22
PATIENT INSIGHTS IN COPD MEDICATION ADHERENCE FROM PHARMACY DATA
Sperber CM, Samarasinghe S, Collins C, Lomax G
Patient Connect, Guildford, UK

PMD105
D23
PATIENT PREFERENCES IN ITALY: HEALTH STATE UTILITIES ASSOCIATED WITH ATTRIBUTES OF WEEKLY INJECTION DEVICES FOR TREATMENT OF TYPE 2 DIABETES
Matza LS1, Boye KS2, Jordan J1, Norrbacka K3, Gentilella R4, Browne C5, Federici MO4, Stewart KD1
1Evidera, Bethesda, MD, USA, 2Eli Lilly and Company, Indianapolis, IN, USA, 3Eli Lilly Finland, Helsinki, Finland, 4Eli Lilly Italia S.p.A., Florence, Italy, 5Evidera, London, UK

PMD106
D24
THE HEALTH-RELATED QUALITY OF LIFE (HRQOL) ASSOCIATED WITH OSTOMY APPLIANCES AND FEATURES
Boisen EB1, Bøgelund M2
1Aalborg University, Aalborg, Denmark, 2Incentive, Holte, Denmark

PMD107
D25
PREDICTING QUALITY ADJUSTED LIFE YEARS USING ST. GEORGE RESPIRATORY RESULTS IN PATIENTS WITH SEVERE EMPHYSEMA TREATED WITH ENDOBRONCHIAL COILS IN ADDITION TO STANDARD OF CARE COMPARED TO STANDARD OF CARE ALONE
Evans R1, Busca R2, Deslee G3, Durand-zaleski I4, Rott C5, Mealing S1
1ICON Health Economics & Epidemiology, Abingdon, UK, 2PneumRx Ltd, London, UK, 3University Hospital, Reims, Reims, France, 4Santé Publique Hôpital Henri Mondor, Creteil, France, 5PneumRx GmbH, Düsseldorf, Germany

PMD108
D26
PATIENT PERCEPTION WITH RESPECT TO THE OVERALL EXPERIENCE TO A PATIENT-FRIENDLY EQUIPMENT DESIGN AND THE IMPACT OF PATIENT-ASSISTED COMPRESSION FEATURE DURING A MAMMOGRAPHY EXAM
Dupuis R1, Peyronnet J1, Das N2
1GE HEALTHCARE, BUC, France, 2GE HEALTHCARE, Richmond VIC, Australia

PMD109
D27
PATIENT-PREFERRED DESIGN FEATURES OF TNF INHIBITOR SELF-INJECTION DEVICES: INSIGHTS FROM A RHEUMATOID ARTHRITIS AUTO-INJECTOR PREFERENCE STUDY
Domańska B1, Mountian I2, Vinconneau G3
1UCB Pharma, Slough, UK, 2UCB Pharma, Brussels, Belgium, 3UCB Pharma, Bulle, Switzerland

PMD110
E1
CAPTURING PATIENT PERSPECTIVES IN THE EVALUATION OF MEDICAL DEVICES: THE CASE OF CENTRAL VENOUS ACCESS DEVICES IN CHEMOTHERAPY
Ryan C, Wu O
University of Glasgow, Glasgow, UK

PMD111
E2
SURVEY OF LIFE QUALITY AMONG PATIENTS WITH INSULIN DEPENDANT DIABETES MELLITUS MANAGED BY INSULIN PUMP
Váradyné Horváth Á1, Noveczky T1, Oláh A1, Pusztai D1, Boncz I1, Szunomár S1, Berta G1, Pakai A2
1University of Pécs, Pécs, Hungary, 2University of Pécs, Zalaegerszeg, Hungary

PMD112
E3
WOMEN'S PREFERENCES: A DISCRETE-CHOICE EXPERIMENT FOR TREATMENT OF MENORRHAGIA WITH UTERUS-PRESERVING THERAPY
Schubert T1, Makowski V2, Vogelmann T1
1LinkCare GmbH, Stuttgart, Germany, 2Hologic Deutschland GmbH, Wiesbaden, Germany

PMD113
E4
HEALTH-RELATED QUALITY-OF-LIFE AND UTILITY MEASURES IMPACT IN A RANDOMIZED CONTROLLED STUDY OF FINE NEEDLE ASPIRATION CYTOLOGY (FNAC) VERSUS WATCHFUL OBSERVATION IN PATIENTS WITH INCIDENTAL SYMPTOMATIC THYROID NODULES
Wong CK, Lang BH
The University of Hong Kong, Hong Kong, Hong Kong

PMD114
E5
COST-EFFECTIVENESS OF REPERFUSION STRATEGIES FOR ST-ELEVATION MYOCARDIAL INFARCTION. REAL-WORLD DATA FROM THE STENT FOR LIFE INITIATIVE IN ITALY
Callea G1, Meregaglia M2, Tarricone R1
1SDA Bocconi School of Management, Milan, Italy, 2Bocconi University, Milan, Italy

PMD115
E6
PUBLIC PERCEPTIONS, ATTITUDES AND WILLINGNESS TO PAY TOWARDS A MEDICAL DEVICE FOR DETECTING FOOT ULCERATION IN PEOPLE WITH DIABETES
Yang F1, Gannon B2, Weightman A1
1University of Manchester, Manchester, UK, 2University of Queensland, Brisbane, Australia

MEDICAL DEVICES/DIAGNOSTICS - Health Care Use & Policy Studies
PMD116
E7
IMPACT OF GENOMIC TESTING BILLING PRACTICES ON UTILIZATION IN ACADEMIC HYBRID ONCOLOGY PRACTICE
Reese ES1, Farhangfar F2, Farhangfar C1, McEachern EN2, Kim ES1, Raghavan D1
1Levine Cancer Institute, Charlotte, NC, USA, 2Levine Cancer Institute, Mint Hill, NC, USA

PMD117
E8
ASSESSMENT OF INNOVATIVE MEDICAL DEVICES: PROVING THE BENEFIT FOR THE PATIENT – BEST PRACTICES FROM GERMANY AND FRANCE
Plaud M, Kuehl MF, Ecker T
Ecker + Ecker GmbH, Hamburg, Germany

PMD118
E9
F-CALPROTECTIN USE IN INFLAMMATORY BOWEL DISEASE IS CHARACTERISED BY IMPROVED DIAGNOSTIC ACCURACY, LESS PATIENT HARM AND DECREASED COSTS, COMPARED WITH CONVENTIONAL SEROLOGICAL MARKERS AND COLONOSCOPY. A SIMULATION STUDY IN THE NETHERLANDS AND IN THE UNITED KINGDOM.
Mascialino B1, Wiertz R2, Vora AA3
1Thermo Fisher Scientific, Uppsala, Sweden, 2Thermo Fisher Scientific, Nieuwegein, The Netherlands, 3Thermo Fisher Scientific, Portage, MI, USA

PMD119
E10
SPIROMETRY COMPARISON OF LUNG FUCTION BETWEEN COALMINERS AND NON-COALMINERS
Ahmed T, Iqbal Q, Minhas M
University of Balochistan, Quetta, Pakistan

PMD120
E11
WHAT STROKE IMAGE DO WE WANT? EUROPEAN CLINICIAN SURVEY ON ACUTE STROKE IMAGING AND REVASCULARISATION TREATMENT
Peultier A1, Redekop WK2, Dippel D3, Bereczki D4, SI Mohamed S5, Douek PC5, Severens JL2
1iBMG, Erasmus University, Rotterdam, The Netherlands, Rotterdam, The Netherlands, 2Erasmus University Rotterdam, Rotterdam, The Netherlands, 3Erasmus MC University, Rotterdam, The Netherlands, 4Semmelweis University, Budapest, Hungary, 5Hospices Civils de Lyon, Lyon, France

PMD121
E12
WHAT ARE THE IMAGES USED TO DIAGNOSE AND ASSESS SUSPECTED STROKES?: A SYSTEMATIC LITERATURE REVIEW OF CARE IN FOUR EUROPEAN COUNTRIES
Peultier A1, Redekop WK2, Severens JL2
1iBMG, Erasmus University, Rotterdam, The Netherlands, Rotterdam, The Netherlands, 2Erasmus University Rotterdam, Rotterdam, The Netherlands

PMD122
E13
BOOSTING HOME DIALYSIS UPTAKE BY SETTING FIXED MODALITY CEILINGS: IS IT AN EVIDENCE-BASED POLICY APPROACH?
Grimm J1, Busink E2, Kendzia D2, Apel C2, Evers S1
1Maastricht University, Maastricht, The Netherlands, 2Fresenius Medical Care, Bad Homburg vor der Höhe, Germany

PMD123
E14
CENTRALIZED PROCUREMENT OF MEDICAL DEVICES IN ITALY: A METHODOLOGY TOWARDS STANDARDIZED TENDER DOSSIER
Borsoi L1, Callea G1, Amatucci F1, Marsilio M1, Rosanna Tarricone RT2
1SDA Bocconi School of Management, Milan, Italy, 2Bocconi University, Milan, Italy

PMD124
E15
VALUE OF NEEDLELESS SAFETY DEVICES FOR IV VORICONAZOLE IN PREVENTION OF NEEDLESTICK INJURY (NSI)
Stephens JM1, Gao X1, Charbonneau C2, Cooke CE3
1Pharmerit International, Bethesda, MD, USA, 2Pfizer P.I.O., Paris, France, 3University of Maryland School of Pharmacy, Baltimore, MD, USA

PMD125
E16
NEW EUROPEAN MEDICAL DEVICE DIRECTIVE (MDD) COMES INTO EFFECT IN 2020: CHANCES AND CONSEQUENCES FOR STAKEHOLDERS
Neeser K1, Mueller E1, Ehreth J2
1Analytica Laser, Loerrach, Germany, 2Analytica Laser, Paris, France

PMD126
E17
REPORTING CLINICAL OUTCOMES IN TAVI REGISTRIES
Kolominsky-Rabas PL, Zhang S
Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany

PMD127
E18
THE EVOLUTION OF NICE MEDTECH INNOVATION BRIEFINGS AND THEIR ASSOCIATED TECHNOLOGIES
Bullen M, Hughes T, Marshall JD
MAP MedTech Limited, Cambridge, UK

PMD128
E19
HTA REPORTS IN GENE AND CELL THERAPY PRODUCTS: A SCOPING REVIEW
Zhang S, Kolominsky-Rabas PL
Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany

PMD129
E20
ECONOMIC OUTCOMES OF THE ATTUNE® KNEE SYSTEM: ANALYSIS OF REAL WORLD LENGTH OF STAY IN AN ITALIAN HOSPITAL
Pipino G1, Paragò V2, Corso KA3, Wigham R4, Holy CE3, Do Rego B5
1L.U.de.S Foundation H.E.I. University, Bologna, Italy, 2Johnson & Johnson Medical SpA, Pratica di Mare (Rome), Italy, 3Johnson & Johnson, New Brunswick, NJ, USA, 4Johnson & Johnson Medical Limited, Livingston, West Lothian, UK, 5DePuy Synthes, Leeds, West Yorkshire, UK

PMD130
E21
COMPETENCY ANALYSIS OF COMMUNITY PHARMACISTS ABOUT CORRECT USE OF METERED DOSE INHALER
Hayat K1, Bukhari NI1, Hussain T2, Saeed H1, Murtaza G3
1University of the Punjab, Lahore, Pakistan, 2University of Veterinary and Animal Sciences, Lahore, Pakistan, 3Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan

PMD131
E22
COST AND OPERATIONAL EFFICIENCY COMPARISON OF AN INTEGRATED VS. A MULTI-STEP SYSTEM FOR EXTRACORPOREAL PHOTOPHERESIS IN GERMANY
Maas C1, Kuchenbecker U1, Kontekakis A2
1Xcenda GmbH, Hannover, Germany, 2Mallinckrodt Pharmaceuticals, Staines-Upon-Thames, UK

PMD132
E23
WITHDRAWN

PMD133
E24
HEALTHCARE RESOURCE UTILIZATION AND COSTS FOR TOTAL HIP ARTHROPLASTY: BENCHMARKING THE ANTERIOR APPROACH IN THE MEDICARE POPULATION
Chitnis A1, Kamath AF2, Lerner J3, Wei D1, Holy CE1
1Johnson & Johnson, New Brunswick, NJ, USA, 2University of Pennsylvania, Philadelphia, PA, USA, 3Johnson & Johnson Medical Devices, Raynham, MA, USA

PMD134
E25
WITHDRAWN

PMD135
E26
COST EFFECTIVENESS OF CONTOUR CURVED CUTTER STAPLER IN LOW ANTERIOR RESECTION IN TURKEY
Tatar M1, Şentürk A1, Turgut CG2, Doğan M2, Türk FC2
1Polar Health Economics & Policy Consultancy, Ankara, Turkey, 2Johnson & Johnson, Istanbul, Turkey

PMD136
E27
A RETROSPECTIVE PREMIER DATABASE STUDY TO COMPARE REPAIR OF VENTRAL HERNIA WITH PHASIXTM VS STRATTICETM IN THE INPATIENT HOSPITAL SURGICAL SETTING
Tripodi D1, Zhang X2, Wan Y2, Berhane I2, Corral M3
1C.R. Bard Inc, Warwick, RI, USA, 2C.R. Bard Inc., Murray Hill, NJ, USA, 3CR BARD, Murray Hill, NJ, USA

PMD137
F1
FEASIBILITY ASSESSMENT: THE IMPACT OF A REDUCED OPERATING ROOM FOOTPRINT SYSTEM ON THE RESOURCES REQUIRED FOR INSTRUMENT MANAGEMENT IN DEFORMITY SURGERY FROM AN ITALIAN HOSPITAL PERSPECTIVE
Taylor H1, Zagra A2, Giudici F2, Scaramuzzo L2, Minoia L2, Archetti M2, Velleca M3, Paragò V3
1Johnson & Johnson Medical Limited, Leeds, UK, 2I.R.C.C.S. Galeazzi Orthopedic Institute, Milan, Italy, 3Johnson & Johnson Medical S.p.A., Pratica di Mare, Italy

PMD138
F2
BUDGET IMPACT ANALYSIS OF P4HB VS PERMANENT SYNTHETIC MESHES IN COMPLEX ABDOMINAL WALL REPAIR IN SPAIN
Busutil R1, Tripodi D2, Corral M3
1Bard España SA, Barcelona, Spain, 2C.R. Bard Inc, Warwick, RI, USA, 3C.R. Bard Inc., Murray Hill, ON, Canada

PMD139
F3
LENGTH OF HOSPITALISATION AFTER ATTUNE® KNEE JOINT ARTHROPLASTY (TKA) - RESULTS OF A GERMAN RETROSPECTIVE DATABASE ANALYSIS
Brüggenjürgen B1, Muehlendyck C2, Gador L2, Katzer A3
1Steinbeis University Berlin, Berlin, Germany, 2Johnson & Johnson Medical GmbH, Norderstedt, Germany, 3ORTHOCLINIC HAMBURG GbR, Hamburg, Germany

PMD140
F4
COST IMPACT ANALYSIS OF NEEDLESTICK INJURIES IN INDIA
Adil M, Sharma M
School of Pharmaceutical Education and Research, Jamia Hamdard (Hamdard University), New Delhi, India

PMD141
F5
COST-EFFECTIVENESS OF PLUROGEL® - A NEW MICELLE-MATRIX-BASED DRESSING WITH 1% SILVER SULPHADIAZINE – IN THE MANAGEMENT OF NON-HEALING WOUNDS
Walter E, Schalle K, Lazic-Peric A, Voit M, Hausberger S
Institute for Pharmaeconomic Research, Vienna, Austria

PMD142
F6
COST EFFECTIVNESS OF INTELIGENT LIVER FUNCTION TEST(ILFT) FOR INVESTIGATING PATIENTS WITH ABNORMAL LIVER FUNCTION TEST
Rezaei Hemami M1, Boyd KA1, Inglis SK2, Dow E3, Dilon JF2
1University of Glasgow, Glasgow, UK, 2University of Dundee, Dundee, UK, 3NHS, Dundee, UK

PMD143
F7
ESTIMATE EUROPEAN CANDIDATES FOR BRONCHOSCOPIC LUNG VOLUME REDUCTION (BLVR) TECHNOLOGIES IN THE TREATMENT OF SEVERE EMPHYSEMA
Busca R1, Rott C2, Witt C3
1PneumRx Ltd, London, UK, 2PneumRx GmbH, Düsseldorf, Germany, 3Charité - Medical University, Berlin, Germany

PMD144
F8
COST-EFFECTIVENESS ANALYSIS OF A POINT-OF-CARE TEST FOR RENAL FUNCTION MEASUREMENT IN COMMUNITY PHARMACIES IN THE NETHERLANDS TO PREVENT ANTIBIOTIC-RELATED HOSPITALIZATIONS
Gout-Zwart J, Olde Hengel E, Postma MJ
University of Groningen, Groningen, The Netherlands

PMD145
F9
COST-SAVINGS IN PROCESS INNOVATIONS; A CASE EXAMPLE IN MYOCARDIAL INFARCTION PATIENTS
Frederix G1, Fischer J2, Abdel-Wahab M3, Richardt G3, Omerovic E4, Neumann F5, Kala P6, Smits P7
1University Medical Centre Utrecht, Utrecht, The Netherlands, 2Health Economics department, Abbott Vascular, Netherlands, The Netherlands, 3Heart Center, Segeberger Kliniken, Bad Segeberg, Germany, 4Sahlsgrenka University Hospital, Gothenburg, Sweden, 5University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany, 6University Hospital Brno and Masaryk University, Brno, Czech Republic, 7Maasstad Hospital, Rotterdam, The Netherlands

PMD146
F10
HOW TO AGGREGATE VARIOUS VALUES OF MEDICAL DEVICES INNOVATION?; A REVIEW OF EMPIRICAL WORK
Park HJ, Kwak M, Jin L, Kim MR, Jung DE
Johnson and Johnson Medical, Seoul, Korea, Republic of (South)

PMD147
F11
OPEN TIBIAL FRACTURES WITH SEGMENTAL DEFECTS: A U.S. RETROSPECTIVE DATABASE ANALYSIS EXAMINING 12-MONTH POST-OPERATIVE PATIENT OUTCOMES AND COSTS
Menzie AM1, Sparks CY2, Tseng RT3, Holy CE4
1DePuy Synthes, Inc., Raynham, MA, USA, 2DePuy Synthes, Inc., West Chester, PA, USA, 3DePuy Synthes Inc., West Chester, PA, USA, 4Johnson & Johnson, New Brunswick, NJ, USA

PMD148
F12
RETROSPECTIVE ANALYSIS OF PATIENTS TREATED WITH COMPUTER-ASSISTED EXTERNAL RING FIXATORS: A DESCRIPTIVE ANALYSIS OF PATIENT DEMOGRAPHICS, HEALTHCARE UNTILIZATION, AND COSTS IN THE U.S.
Menzie AM1, Sparks CY2, Holy CE3
1DePuy Synthes, Inc., Raynham, MA, USA, 2DePuy Synthes, Inc., West Chester, PA, USA, 3Johnson & Johnson, New Brunswick, NJ, USA

PMD149
F13
FEASIBILITY AND ACCEPTABILITY OF ATRIAL FIBRILLATION SCREENING USING A HAND-HELD ECG DEVICE IN GENERAL PRACTICE SETTING IN HONG KONG
Chan LL, Chan SC, Yan BP
The Chinese University of Hong Kong, Shatin, Hong Kong

PMD150
F14
REDETS. 10 YEARS OF FULL ECONOMIC HEALTH TECHNOLOGIES ASSESSMENTS (MEDICAL DEVICES) IN SPAIN (2006-2016)
Gimenez E1, Espallargues M1, Vella V1, Asua J2, Gutierrez MA2, Bayon JC2, Rosendo B3, Varela L3, Molina MT4, Marquez S4, Serrano P5, Garcia L5, Spanish Network of HTA R6
1Agencia de Qualitat i Avaluació Sanitàries de Catalunya, Barcelona, Spain, 2Basque Office HTA - Osteba, Vitoria, Spain, 3AVALIA-T, Santiago de Compostela, Spain, 4Agencia de Evaluación de Tecnologías Sanitarias de Andalucía, Sevilla, Spain, 5HTA unit of the Health Service of The Canary Islands (SESCS), El Rosario (Tenerife), Spain, 6Ministerio de Sanidad, Servicios Sociales e Igualdad, Madrid, Spain

PMD151
F15
THE ROLE OF MEDICAL TECHNOLOGIES IN REVOLUTIONISING THE NHS IN ENGLAND: A REVIEW OF SUSTAINABILITY AND TRANSFORMATION PLANS (STPS)
Bullen M, Marshall JD, Hughes T
MAP MedTech Limited, Cambridge, UK

PMD152
F16
EXAMINING GLOBAL OCCURRENCE OF COMPLICATIONS RELATED TO PERIPHERAL IV CATHETERS USING A FOCUSED LITERATURE REVIEW
Bal V, Tripathi S, Yang W
Becton Dickinson, Franklin Lakes, NJ, USA

PMD153
WITHDRAWN

PMD154
F17
COMPARISON OF CATHETER-RELATED COMPLICATIONS BETWEEN MANUALLY-PREPARED SALINE FLUSH SYRINGES AND COMMERCIALLY AVAILABLE PRE-FILLED SALINE FLUSH SYRINGES
Bal V1, Culiner J1, Nyarko E2
1BD Medical, Franklin Lakes, NJ, USA, 2BD Medical, Medication and Procedural Solutions, Franklin lakes, NJ, USA

PMD155
F18
A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS IN ROBOT-ASSISTED HYSTERECTOMY USE FOR CERVICAL CANCER COMPARED WITH OPEN AND LAPAROSCOPIC SURGERY
Sui B1, Zhao K2, Wang Y2, Gao Y3
1Beijing Normal Univeristy, Beijing, China, 2China National Health Development Research Center, Beijing, China, 3Chongqing Technology and Business University, Chongqing, China

PMD156
F19
DOES THE NICE DIAGNOSTICS ASSESSMENT PROGRAMME USE AN EMPIRICAL ICER THRESHOLD?
Chen G, Koczula KM, Peirce VJ, Marsh W
Costello Medical Consulting Ltd, Cambridge, UK

PMD157
F20
HOW SHOULD WE TEST FOR PRE-TERM LABOUR? AN ECONOMIC MODEL AND COST-EFFECTIVENESS ANALYSIS
Heggie R1, Boyd K1, Stock S2, Bruijn M2
1University of Glasgow, Glasgow, UK, 2University of Edinburgh, Edinburgh, UK

PMD158
F21
POCT COST EFFECTIVENESS CASE STUDY ON THE WAY TO A HB-HTA UNIT
Rogalewicz V1, Matuskova K2, Zavadil M3, Vaclavikova A1, Kamensky V1
1Czech Technical University in Prague, Kladno, Czech Republic, 2Institute of Health Information and Statistics of the Czech Republic, Praha 2, Czech Republic, 3Motol University Hospital, Prague, Czech Republic

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.